Depressive Disorder Market, Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: D3C1175810C6EN
Market Monitor Global

Abstracts

Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including genes, factors such as stress and brain chemistry that could lead to depression.

This report contains market size and forecasts of Depressive Disorder in Global, including the following market information:

Global Depressive Disorder Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Depressive Disorder market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tricyclic Antidepressants Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Depressive Disorder include Alkermes, Allergan, Bristol Myers Squibb, Eli Lilly, Glaxosmithkline, H. Lundbeck, Merck, Pfizer and Teva Pharmaceutical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Depressive Disorder companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Depressive Disorder Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Depressive Disorder Market Segment Percentages, by Type, 2021 (%)

• Tricyclic Antidepressants
• Selective Serotonin Reuptake Inhibitors
• Serotonin-Norepinephrine Reuptake Inhibitors
• Monoamine Oxidase Inhibitors
• Serotonin Antagonist And Reuptake Inhibitors
• Others

Global Depressive Disorder Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Depressive Disorder Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Homecare Settings
• Long Term Care Centers

Global Depressive Disorder Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Depressive Disorder Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Depressive Disorder revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Depressive Disorder revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Alkermes
• Allergan
• Bristol Myers Squibb
• Eli Lilly
• Glaxosmithkline
• H. Lundbeck
• Merck
• Pfizer
• Teva Pharmaceutical
• Takeda Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Depressive Disorder Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Depressive Disorder Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DEPRESSIVE DISORDER OVERALL MARKET SIZE

2.1 Global Depressive Disorder Market Size: 2021 VS 2028
2.2 Global Depressive Disorder Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Depressive Disorder Players in Global Market
3.2 Top Global Depressive Disorder Companies Ranked by Revenue
3.3 Global Depressive Disorder Revenue by Companies
3.4 Top 3 and Top 5 Depressive Disorder Companies in Global Market, by Revenue in 2021
3.5 Global Companies Depressive Disorder Product Type
3.6 Tier 1, Tier 2 and Tier 3 Depressive Disorder Players in Global Market
  3.6.1 List of Global Tier 1 Depressive Disorder Companies
  3.6.2 List of Global Tier 2 and Tier 3 Depressive Disorder Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Depressive Disorder Market Size Markets, 2021 & 2028
  4.1.2 Tricyclic Antidepressants
  4.1.3 Selective Serotonin Reuptake Inhibitors
  4.1.4 Serotonin-Norepinephrine Reuptake Inhibitors
  4.1.5 Monoamine Oxidase Inhibitors
  4.1.6 Serotonin Antagonist And Reuptake Inhibitors
  4.1.7 Others
4.2 By Type - Global Depressive Disorder Revenue & Forecasts
  4.2.1 By Type - Global Depressive Disorder Revenue, 2017-2022
  4.2.2 By Type - Global Depressive Disorder Revenue, 2023-2028
  4.2.3 By Type - Global Depressive Disorder Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Depressive Disorder Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Ambulatory Surgical Centers
  5.1.4 Diagnostic Centers
  5.1.5 Homecare Settings
  5.1.6 Long Term Care Centers
5.2 By Application - Global Depressive Disorder Revenue & Forecasts
  5.2.1 By Application - Global Depressive Disorder Revenue, 2017-2022
  5.2.2 By Application - Global Depressive Disorder Revenue, 2023-2028
  5.2.3 By Application - Global Depressive Disorder Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Depressive Disorder Market Size, 2021 & 2028
6.2 By Region - Global Depressive Disorder Revenue & Forecasts
  6.2.1 By Region - Global Depressive Disorder Revenue, 2017-2022
  6.2.2 By Region - Global Depressive Disorder Revenue, 2023-2028
  6.2.3 By Region - Global Depressive Disorder Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Depressive Disorder Revenue, 2017-2028
  6.3.2 US Depressive Disorder Market Size, 2017-2028
  6.3.3 Canada Depressive Disorder Market Size, 2017-2028
  6.3.4 Mexico Depressive Disorder Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Depressive Disorder Revenue, 2017-2028
  6.4.2 Germany Depressive Disorder Market Size, 2017-2028
  6.4.3 France Depressive Disorder Market Size, 2017-2028
  6.4.4 U.K. Depressive Disorder Market Size, 2017-2028
  6.4.5 Italy Depressive Disorder Market Size, 2017-2028
  6.4.6 Russia Depressive Disorder Market Size, 2017-2028
  6.4.7 Nordic Countries Depressive Disorder Market Size, 2017-2028
  6.4.8 Benelux Depressive Disorder Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Depressive Disorder Revenue, 2017-2028
  6.5.2 China Depressive Disorder Market Size, 2017-2028
  6.5.3 Japan Depressive Disorder Market Size, 2017-2028
  6.5.4 South Korea Depressive Disorder Market Size, 2017-2028
  6.5.5 Southeast Asia Depressive Disorder Market Size, 2017-2028
  6.5.6 India Depressive Disorder Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Depressive Disorder Revenue, 2017-2028
  6.6.2 Brazil Depressive Disorder Market Size, 2017-2028
  6.6.3 Argentina Depressive Disorder Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Depressive Disorder Revenue, 2017-2028
  6.7.2 Turkey Depressive Disorder Market Size, 2017-2028
  6.7.3 Israel Depressive Disorder Market Size, 2017-2028
  6.7.4 Saudi Arabia Depressive Disorder Market Size, 2017-2028
  6.7.5 UAE Depressive Disorder Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Alkermes
  7.1.1 Alkermes Corporate Summary
  7.1.2 Alkermes Business Overview
  7.1.3 Alkermes Depressive Disorder Major Product Offerings
  7.1.4 Alkermes Depressive Disorder Revenue in Global Market (2017-2022)
  7.1.5 Alkermes Key News
7.2 Allergan
  7.2.1 Allergan Corporate Summary
  7.2.2 Allergan Business Overview
  7.2.3 Allergan Depressive Disorder Major Product Offerings
  7.2.4 Allergan Depressive Disorder Revenue in Global Market (2017-2022)
  7.2.5 Allergan Key News
7.3 Bristol Myers Squibb
  7.3.1 Bristol Myers Squibb Corporate Summary
  7.3.2 Bristol Myers Squibb Business Overview
  7.3.3 Bristol Myers Squibb Depressive Disorder Major Product Offerings
  7.3.4 Bristol Myers Squibb Depressive Disorder Revenue in Global Market (2017-2022)
  7.3.5 Bristol Myers Squibb Key News
7.4 Eli Lilly
  7.4.1 Eli Lilly Corporate Summary
  7.4.2 Eli Lilly Business Overview
  7.4.3 Eli Lilly Depressive Disorder Major Product Offerings
  7.4.4 Eli Lilly Depressive Disorder Revenue in Global Market (2017-2022)
  7.4.5 Eli Lilly Key News
7.5 Glaxosmithkline
  7.5.1 Glaxosmithkline Corporate Summary
  7.5.2 Glaxosmithkline Business Overview
  7.5.3 Glaxosmithkline Depressive Disorder Major Product Offerings
  7.5.4 Glaxosmithkline Depressive Disorder Revenue in Global Market (2017-2022)
  7.5.5 Glaxosmithkline Key News
7.6 H. Lundbeck
  7.6.1 H. Lundbeck Corporate Summary
  7.6.2 H. Lundbeck Business Overview
  7.6.3 H. Lundbeck Depressive Disorder Major Product Offerings
  7.6.4 H. Lundbeck Depressive Disorder Revenue in Global Market (2017-2022)
  7.6.5 H. Lundbeck Key News
7.7 Merck
  7.7.1 Merck Corporate Summary
  7.7.2 Merck Business Overview
  7.7.3 Merck Depressive Disorder Major Product Offerings
  7.7.4 Merck Depressive Disorder Revenue in Global Market (2017-2022)
  7.7.5 Merck Key News
7.8 Pfizer
  7.8.1 Pfizer Corporate Summary
  7.8.2 Pfizer Business Overview
  7.8.3 Pfizer Depressive Disorder Major Product Offerings
  7.8.4 Pfizer Depressive Disorder Revenue in Global Market (2017-2022)
  7.8.5 Pfizer Key News
7.9 Teva Pharmaceutical
  7.9.1 Teva Pharmaceutical Corporate Summary
  7.9.2 Teva Pharmaceutical Business Overview
  7.9.3 Teva Pharmaceutical Depressive Disorder Major Product Offerings
  7.9.4 Teva Pharmaceutical Depressive Disorder Revenue in Global Market (2017-2022)
  7.9.5 Teva Pharmaceutical Key News
7.10 Takeda Pharmaceutical
  7.10.1 Takeda Pharmaceutical Corporate Summary
  7.10.2 Takeda Pharmaceutical Business Overview
  7.10.3 Takeda Pharmaceutical Depressive Disorder Major Product Offerings
  7.10.4 Takeda Pharmaceutical Depressive Disorder Revenue in Global Market (2017-2022)
  7.10.5 Takeda Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Depressive Disorder Market Opportunities & Trends in Global Market
Table 2. Depressive Disorder Market Drivers in Global Market
Table 3. Depressive Disorder Market Restraints in Global Market
Table 4. Key Players of Depressive Disorder in Global Market
Table 5. Top Depressive Disorder Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Depressive Disorder Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Depressive Disorder Revenue Share by Companies, 2017-2022
Table 8. Global Companies Depressive Disorder Product Type
Table 9. List of Global Tier 1 Depressive Disorder Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Depressive Disorder Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Depressive Disorder Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Depressive Disorder Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Depressive Disorder Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Depressive Disorder Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Depressive Disorder Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Depressive Disorder Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Depressive Disorder Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Depressive Disorder Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Depressive Disorder Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Depressive Disorder Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Depressive Disorder Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Depressive Disorder Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Depressive Disorder Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Depressive Disorder Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Depressive Disorder Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Depressive Disorder Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Depressive Disorder Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Depressive Disorder Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Depressive Disorder Revenue, (US$, Mn), 2023-2028
Table 30. Alkermes Corporate Summary
Table 31. Alkermes Depressive Disorder Product Offerings
Table 32. Alkermes Depressive Disorder Revenue (US$, Mn), (2017-2022)
Table 33. Allergan Corporate Summary
Table 34. Allergan Depressive Disorder Product Offerings
Table 35. Allergan Depressive Disorder Revenue (US$, Mn), (2017-2022)
Table 36. Bristol Myers Squibb Corporate Summary
Table 37. Bristol Myers Squibb Depressive Disorder Product Offerings
Table 38. Bristol Myers Squibb Depressive Disorder Revenue (US$, Mn), (2017-2022)
Table 39. Eli Lilly Corporate Summary
Table 40. Eli Lilly Depressive Disorder Product Offerings
Table 41. Eli Lilly Depressive Disorder Revenue (US$, Mn), (2017-2022)
Table 42. Glaxosmithkline Corporate Summary
Table 43. Glaxosmithkline Depressive Disorder Product Offerings
Table 44. Glaxosmithkline Depressive Disorder Revenue (US$, Mn), (2017-2022)
Table 45. H. Lundbeck Corporate Summary
Table 46. H. Lundbeck Depressive Disorder Product Offerings
Table 47. H. Lundbeck Depressive Disorder Revenue (US$, Mn), (2017-2022)
Table 48. Merck Corporate Summary
Table 49. Merck Depressive Disorder Product Offerings
Table 50. Merck Depressive Disorder Revenue (US$, Mn), (2017-2022)
Table 51. Pfizer Corporate Summary
Table 52. Pfizer Depressive Disorder Product Offerings
Table 53. Pfizer Depressive Disorder Revenue (US$, Mn), (2017-2022)
Table 54. Teva Pharmaceutical Corporate Summary
Table 55. Teva Pharmaceutical Depressive Disorder Product Offerings
Table 56. Teva Pharmaceutical Depressive Disorder Revenue (US$, Mn), (2017-2022)
Table 57. Takeda Pharmaceutical Corporate Summary
Table 58. Takeda Pharmaceutical Depressive Disorder Product Offerings
Table 59. Takeda Pharmaceutical Depressive Disorder Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Depressive Disorder Segment by Type in 2021
Figure 2. Depressive Disorder Segment by Application in 2021
Figure 3. Global Depressive Disorder Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Depressive Disorder Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Depressive Disorder Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Depressive Disorder Revenue in 2021
Figure 8. By Type - Global Depressive Disorder Revenue Market Share, 2017-2028
Figure 9. By Application - Global Depressive Disorder Revenue Market Share, 2017-2028
Figure 10. By Region - Global Depressive Disorder Revenue Market Share, 2017-2028
Figure 11. By Country - North America Depressive Disorder Revenue Market Share, 2017-2028
Figure 12. US Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Depressive Disorder Revenue Market Share, 2017-2028
Figure 16. Germany Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 17. France Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Depressive Disorder Revenue Market Share, 2017-2028
Figure 24. China Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 28. India Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Depressive Disorder Revenue Market Share, 2017-2028
Figure 30. Brazil Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Depressive Disorder Revenue Market Share, 2017-2028
Figure 33. Turkey Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Depressive Disorder Revenue, (US$, Mn), 2017-2028
Figure 37. Alkermes Depressive Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Allergan Depressive Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol Myers Squibb Depressive Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eli Lilly Depressive Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Glaxosmithkline Depressive Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. H. Lundbeck Depressive Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Depressive Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pfizer Depressive Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Teva Pharmaceutical Depressive Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Takeda Pharmaceutical Depressive Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)